Bioviventis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 36,612 | 23,284 | 16,418 | 17,893 | 22,386 | 22,811 | 18,612 | 22,725 |
| Profit before tax | 4,347 | 971 | -2,977 | -2,439 | -3,090 | -2,805 | -4,417 | -9,703 |
| Net profit | 4,121 | 900 | -2,977 | -2,439 | -3,090 | -2,805 | -4,417 | -9,703 |
| Equity | 5,631 | 6,531 | 3,554 | 1,116 | -1,973 | -4,778 | -4,909 | -9,318 |
| Liabilities | 2,622 | 2,991 | 1,039 | 6,720 | 8,671 | 10,342 | 14,125 | 15,649 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 8,253 | 9,522 | 4,526 | 7,774 | 6,623 | 5,486 | 9,134 | 6,331 |
| Total assets | 8,253 | 9,522 | 4,526 | 7,774 | 6,623 | 5,486 | 9,134 | 6,331 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,220 | 1,522 | 2,618 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +109.6% | -36.4% | -29.5% | +9.0% | +25.1% | +1.9% | -18.4% | +22.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 49.9% | 9.5% | -65.8% | -31.4% | -46.7% | -51.1% | -48.4% | -153.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 73.2% | 13.8% | -83.8% | -218.5% | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 11.3% | 3.9% | -18.1% | -13.6% | -13.8% | -12.3% | -23.7% | -42.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 11.9% | 4.2% | -18.1% | -13.6% | -13.8% | -12.3% | -23.7% | -42.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.5 | 0.3 | 6.0 | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 13,729 | 11,642 | 8,209 | 14,314 | 22,386 | 22,811 | 18,612 | 22,725 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bioviventis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-16 | 2026-08-17 | 0.52 |
| 2026-07-23 | 2026-08-14 | 0.52 |
| 2026-07-19 | 2026-07-19 | 129.11 |
| 2026-07-16 | 2026-07-17 | 129.11 |
| 2026-06-16 | 2026-06-24 | 129.11 |
| 2026-01-22 | 2026-02-16 | 0.10 |
| 2025-12-16 | 2025-12-17 | 129.11 |
| 2025-10-23 | 2025-11-16 | 0.92 |
| 2025-09-16 | 2025-09-24 | 129.11 |
| 2025-08-28 | 2025-08-29 | 129.38 |
| 2025-08-19 | 2025-08-24 | 129.38 |
| 2025-07-25 | 2025-08-18 | 0.27 |
| 2025-07-24 | 2025-07-24 | 129.38 |
| 2025-07-16 | 2025-07-23 | 129.04 |
| 2025-04-30 | 2025-04-30 | 128.46 |
| 2025-04-16 | 2025-04-23 | 128.46 |
| 2025-03-21 | 2025-03-25 | 109.09 |
| 2025-03-18 | 2025-03-20 | 128.46 |
| 2025-01-22 | 2025-01-23 | 128.46 |
| 2025-01-16 | 2025-01-21 | 127.95 |
| 2024-11-18 | 2024-11-20 | 130.27 |
| 2024-10-24 | 2024-11-17 | 1.16 |
| 2024-10-16 | 2024-10-22 | 129.11 |
| 2024-09-17 | 2024-09-24 | 129.11 |
| 2024-08-19 | 2024-08-27 | 129.51 |
| 2024-07-25 | 2024-08-18 | 0.40 |
| 2024-07-24 | 2024-07-24 | 129.51 |
| 2024-07-16 | 2024-07-23 | 129.11 |
| 2024-06-18 | 2024-06-18 | 129.11 |
| 2024-05-16 | 2024-05-19 | 130.09 |
| 2024-04-24 | 2024-05-15 | 0.98 |
| 2024-04-23 | 2024-04-23 | 52.63 |
| 2024-04-16 | 2024-04-22 | 51.65 |
| 2024-03-18 | 2024-03-24 | 64.55 |
| 2024-02-19 | 2024-02-25 | 52.82 |
| 2024-01-23 | 2024-01-30 | 130.08 |
| 2024-01-16 | 2024-01-22 | 129.11 |
| 2023-12-18 | 2024-01-01 | 129.11 |
| 2023-11-16 | 2023-11-21 | 129.79 |
| 2023-10-25 | 2023-11-15 | 0.68 |
| 2023-08-17 | 2023-08-24 | 129.08 |
| 2023-07-26 | 2023-07-26 | 129.11 |
| 2023-07-24 | 2023-07-25 | 130.35 |
| 2023-07-18 | 2023-07-23 | 129.11 |
| 2023-06-16 | 2023-06-22 | 129.11 |
| 2023-05-16 | 2023-05-28 | 129.62 |
| 2023-05-02 | 2023-05-15 | 0.51 |
| 2023-04-27 | 2023-04-28 | 0.51 |
| 2023-04-26 | 2023-04-26 | 129.62 |
| 2023-04-18 | 2023-04-25 | 129.11 |
| 2023-03-16 | 2023-03-27 | 20.08 |
| 2023-01-24 | 2023-01-26 | 130.04 |
| 2023-01-23 | 2023-01-23 | 129.11 |
| 2023-01-20 | 2023-01-22 | 130.04 |
| 2023-01-17 | 2023-01-19 | 129.11 |
| 2022-12-16 | 2022-12-22 | 129.11 |
| 2022-11-21 | 2022-11-30 | 129.84 |
| 2022-11-17 | 2022-11-18 | 129.84 |
| 2022-10-28 | 2022-11-16 | 0.73 |
| 2022-09-16 | 2022-09-18 | 129.11 |
| 2022-08-23 | 2022-08-23 | 129.11 |
| 2022-07-27 | 2022-08-22 | 0.78 |
| 2022-07-25 | 2022-07-26 | 129.89 |
| 2022-07-18 | 2022-07-24 | 129.11 |
| 2022-06-16 | 2022-06-29 | 129.11 |
| 2022-04-28 | 2022-05-11 | 0.44 |
| 2022-04-19 | 2022-04-21 | 93.89 |
| 2022-03-16 | 2022-03-17 | 47.57 |
| 2022-02-17 | 2022-02-23 | 99.11 |
| 2022-01-31 | 2022-02-16 | 0.74 |
| 2022-01-18 | 2022-01-20 | 111.50 |
| 2021-12-16 | 2021-12-21 | 77.47 |
| 2021-11-16 | 2021-11-24 | 130.15 |
| 2021-11-05 | 2021-11-15 | 1.04 |
| 2021-10-18 | 2021-10-19 | 129.11 |
| 2021-09-16 | 2021-09-26 | 129.11 |
Bioviventis - VMI tax arrears
As of 2026-09-14, the amount of overdue STI tax debt of the company Bioviventis is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-30 | 2026-09-14 | 0.32 |
| 2026-07-30 | 2026-08-26 | 0.04 |
| 2026-04-30 | 2026-05-25 | 0.06 |
| 2026-03-29 | 2026-04-28 | 0.1 |
| 2026-02-28 | 2026-03-27 | 0.12 |
| 2026-02-27 | 2026-02-27 | 0.28 |
| 2026-02-21 | 2026-02-26 | 2.28 |
| 2026-02-03 | 2026-02-20 | 0.28 |
| 2026-01-29 | 2026-01-30 | 269.07 |
| 2026-01-15 | 2026-01-28 | 0.07 |
| 2026-01-05 | 2026-01-05 | 278.32 |
| 2026-01-01 | 2026-01-04 | 278.18 |
| 2025-11-28 | 2025-12-31 | 0.04 |
| 2025-11-22 | 2025-11-25 | 1.02 |
| 2025-10-30 | 2025-11-21 | 0.02 |
| 2025-10-02 | 2025-10-29 | 0.15 |
| 2025-09-28 | 2025-10-01 | 573.0 |
| 2025-07-30 | 2025-08-25 | 0.2 |
| 2025-07-28 | 2025-07-29 | 183.09 |
| 2025-06-28 | 2025-07-27 | 0.09 |
| 2025-06-27 | 2025-06-27 | 0.02 |
| 2025-06-25 | 2025-06-26 | 35.67 |
| 2025-06-24 | 2025-06-24 | 35.07 |
| 2025-05-29 | 2025-06-23 | 0.07 |
| 2025-04-30 | 2025-05-24 | 0.24 |
| 2025-04-28 | 2025-04-29 | 230.0 |
| 2025-02-28 | 2025-02-28 | 0.07 |
| 2025-02-01 | 2025-02-01 | 0.03 |
| 2025-01-30 | 2025-01-31 | 113.05 |
| 2025-01-03 | 2025-01-29 | 0.02 |
| 2025-01-01 | 2025-01-02 | 52.44 |
| 2024-12-31 | 2024-12-31 | 52.4 |
| 2024-12-30 | 2024-12-30 | 52.41 |
| 2024-12-03 | 2024-12-03 | 41.67 |
| 2024-11-28 | 2024-12-02 | 41.64 |
| 2024-11-14 | 2024-11-27 | 0.62 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Bioviventis, UAB (code 304059807) is a Private Limited Liability Company engaged in non-specialised wholesale trade. In 2025, the company generated EUR 22.7K in revenue, compared with EUR 18.6K in 2024 and EUR 22.8K in 2023, indicating a broadly flat two-year trajectory with a 22.1% increase year on year in the latest period. Profitability remained negative throughout the period and weakened in 2025, when net loss reached EUR 9.7K after a loss of EUR 4.4K in 2024 and EUR 2.8K in 2023. The 2025 profit margin was -42.7%. The balance sheet also remained tight: total assets were EUR 6.3K, equity was negative at EUR -9.3K, and liabilities stood at EUR 15.6K. Assets declined from EUR 9.1K in 2024, while liabilities continued to rise. Efficiency indicators suggest limited scale, with revenue per employee at EUR 22.7K and profit per employee at EUR -9.7K in 2025. Return ratios are distorted by the very small and negative equity base.